{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:34:28Z","timestamp":1794562468417,"version":"4.9.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T00:00:00Z","timestamp":1528156800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T00:00:00Z","timestamp":1528156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004421","name":"World Bank Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004421","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40360-018-0220-7","type":"journal-article","created":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T13:19:05Z","timestamp":1528204745000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Determinants of anti-retroviral regimen changes among HIV\/AIDS patients of east and west Wollega zone health institutions, Oromia region, west Ethiopia: a cross-sectional study"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7321-8324","authenticated-orcid":false,"given":"Amsalu","family":"Bokore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belay","family":"Korme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getu","family":"Bayisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,5]]},"reference":[{"key":"220_CR1","unstructured":"Food, Medicine and Health Care Administration and Control Authority (FMHACA); Standard Treatment Guidelines for general hospitals; 3rd edition; Addis Ababa. Ethiopia 2014."},{"key":"220_CR2","unstructured":"World Health organization (WHO); Fact Sheet; 2015."},{"key":"220_CR3","volume-title":"Ethiopia demographic and health survey","author":"Central Statistical Agency Ethiopia and ICF International","year":"2012","unstructured":"Central Statistical Agency Ethiopia and ICF International. Ethiopia demographic and health survey. Addis Ababa, Ethiopia and Calverton, Maryland: Central Statistical Agency and ICF International; 2012."},{"key":"220_CR4","unstructured":"World Health Organization (WHO). HIV\/AIDS Progress in 2014; Update Ethiopia, WHO country office for Ethiopia UNECA compound; Addis Ababa, Ethiopia; March 2015."},{"key":"220_CR5","volume-title":"Country progress reports on HIV\/AIDS; Addis Ababa, Ethiopia","author":"Federal democratic republic of Ethiopia","year":"2012","unstructured":"Federal democratic republic of Ethiopia. Country progress reports on HIV\/AIDS; Addis Ababa, Ethiopia; 2012."},{"key":"220_CR6","unstructured":"Federal Ministry of Health (MOH). Health Sector Development Program IV: (2010\/11\u20132014\/15), Final draft. Addis Ababa, Ethiopia: MOH. p. 2010."},{"key":"220_CR7","first-page":"782","volume":"12","author":"T Wilkin","year":"2010","unstructured":"Wilkin T, Marshall G, Gulick M. Switching antiretroviral therapy why, when and how. J Acquir Immune Defic Syndr. 2010;12:782\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"220_CR8","volume-title":"Global update on HIV treatment: results, impact and opportunities, brief summary","author":"World Health organization (WHO)","year":"2013","unstructured":"World Health organization (WHO). Global update on HIV treatment: results, impact and opportunities, brief summary. Kuala Lumpur, Malaysia: WHO; 2013a."},{"key":"220_CR9","volume-title":"Guideline for implantation of the antiretroviral therapy program in Ethiopia","author":"Federal Ministry of Health (MOH)","year":"2007","unstructured":"Federal Ministry of Health (MOH). Guideline for implantation of the antiretroviral therapy program in Ethiopia. Addis Ababa, Ethiopia: MOH; 2007."},{"issue":"1","key":"220_CR10","first-page":"1","volume":"15","author":"T Jima","year":"2013","unstructured":"Jima T, Angamo M, Wabe N. Causes for antiretroviral regimen change among HIV\/AIDS patients in Addis Ababa. Ethiopia Tanzania Journal of Health Research. 2013;15(1):1\u20139.","journal-title":"Ethiopia Tanzania Journal of Health Research"},{"issue":"8","key":"220_CR11","first-page":"794","volume":"23","author":"B Park","year":"2010","unstructured":"Park B, Choe G, Kim H, et al. Early modification of initial HAART regimen associated with poor clinical outcome in HIV patients. AIDS Res Hum Retrovir. 2010;23(8):794\u2013800.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"3","key":"220_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/QAI.0b013e31816fdc5f","volume":"48","author":"S Hendrickson","year":"2008","unstructured":"Hendrickson S, Jacobson P, Nelson W, et al. Host genetic influences on highly active antiretroviral therapy efficacy and AIDS free survival. J Acquire Immune Deficient Syndrome. 2008;48(3):263\u201371.","journal-title":"J Acquire Immune Deficient Syndrome"},{"issue":"2","key":"220_CR13","first-page":"320","volume":"3","author":"R Demessie","year":"2014","unstructured":"Demessie R, Mekonnen A, Amogne W, et al. Knowledge and adherence to antiretroviral therapy among adult people living with HIV \/ AIDS at TikurAnbessa specialized hospital, Ethiopia. International Journal of Basic & Clinical Pharmacology. 2014;3(2):320\u201330.","journal-title":"International Journal of Basic & Clinical Pharmacology"},{"key":"220_CR14","unstructured":"Nekemte town health Office (NTHO) Census 2009."},{"issue":"4","key":"220_CR15","first-page":"116","volume":"2","author":"Y Mekonnen","year":"2014","unstructured":"Mekonnen Y, Molla G. Reason for regimen change among HIV patients on initial highly active antiretroviral therapy in Bedele. Journal of Biotechnology and Bio safety. 2014;2(4):116\u201322.","journal-title":"Journal of Biotechnology and Bio safety"},{"issue":"1","key":"220_CR16","first-page":"120","volume":"3","author":"A Mulugeta","year":"2012","unstructured":"Mulugeta A, Chane T. Causes of antiretroviral drug changes among patients on antiretroviral therapy. Int J Pharm Sci Res. 2012;3(1):120\u20135.","journal-title":"Int J Pharm Sci Res"},{"issue":"1","key":"220_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/QAD.0b013e32832ec1c3","volume":"24","author":"E Messou","year":"2010","unstructured":"Messou E, Anglaret X, Duvignac J, et al. Antiretroviral treatment changes in adults from C\u00f4te d\u2019Ivoire: the roles of tuberculosis and pregnancy. AIDS (London, England). 2010;24(1):93\u20139.","journal-title":"AIDS (London, England)"},{"issue":"5","key":"220_CR18","first-page":"117","volume":"7","author":"B Sandeep","year":"2014","unstructured":"Sandeep B, Vansant C, Raghunandan M, et al. Factors influencing the substitution of antiretroviral therapy in human immunodeficiency virus\/acquired immunodeficiency syndrome patients on first line highly active antiretroviral therapy. Asian Journal of Pharmaceutical and Clinical Research. 2014;7(5):117\u201320.","journal-title":"Asian Journal of Pharmaceutical and Clinical Research"},{"issue":"1","key":"220_CR19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.5455\/2319-2003.ijbcp20140201","volume":"3","author":"T Bayou","year":"2014","unstructured":"Bayou T, Woldu M, Gebre Meskel G, et al. Factors determinant for change of initial antiretroviral treatment regimen among patients on ART follow-up clinic of Mekelle hospital, Mekelle, Ethiopia. International Journal of Basic & Clinical Pharmacology. 2014;3(1):44.","journal-title":"International Journal of Basic & Clinical Pharmacology"},{"key":"220_CR20","doi-asserted-by":"crossref","unstructured":"Zhou J, Kumarasamy N, Boyd M, et al. Deferred modification of antiretroviral regimen following documented treatment failure in Asia: Results from the TREAT Asia HIV Observational Database (TAHOD). HIV Medicine. 2010;11(1):31\u20139.","DOI":"10.1111\/j.1468-1293.2009.00738.x"},{"issue":"3","key":"220_CR21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/QAI.0b013e318050d66c","volume":"45","author":"C Hawkins","year":"2009","unstructured":"Hawkins C, Achenbach C, Fryda W, et al. Antiretroviral durability and tolerability in HIV-infected adults living in urban Kenya. J Acquir Immune Defic Syndr. 2009;45(3):304\u201310.","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-018-0220-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40360-018-0220-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-018-0220-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T08:37:42Z","timestamp":1720341462000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-018-0220-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,5]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["220"],"URL":"https:\/\/doi.org\/10.1186\/s40360-018-0220-7","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,5]]},"assertion":[{"value":"15 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AB is graduated from Jimma University with bachelor of pharmacy, from Unity University with bachelor of arts degree in economics and from Wollega University with masters of public health and has published many original research articles in an international journals, is currently working at Nekemte referral hospital chronic care pharmacy, P.O. Box\u00a025, Nekemte, Ethiopia. BK is graduated from Wollega University with bachelor of pharmacy, is currently working at Nekemte referral hospital chronic care pharmacy, P.O. Box\u00a025, Nekemte, Ethiopia. GB has also published many original research articles in an international journals, is currently a lecturer at Wollega University College of health and medical sciences, department of pharmacy, P.O. Box\u00a0395, Nekemte, Ethiopia.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"The study was approved by the ethical review committee of Wollega University. Official letter from the University explaining the aim of the study was submitted to zonal and woreda health offices of east and west Wollega zone and support of the administration was obtained prior to pursuing the study. Informed written consent was obtained from the study participants before data collection and clinical review of patients which was already recorded was used; confidentiality and anonymity of subject was maintained by not recording and identifying details, such as name or any other personal identifiers. No disclosure of any name of the patients, the healthcare provider or drug product was made in relation to the finding. Only numerical identifications were used as a reference. All data forms were stored in a confidential and secure place.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"28"}}